1361216-28-5

Basic information

• Product Name: (2S)-1,1,1-trifluoro-2-(4-(4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol
• CAS NO: 1361216-28-5
• Molecular Weight: 420.477
• Mol File: 1361216-28-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S)-1,1,1-trifluoro-2-(4-(4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-1,1,1-trifluoro-2-(4-(4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol(1361216-28-5)
• EPA Substance Registry System: (2S)-1,1,1-trifluoro-2-(4-(4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol(1361216-28-5)

Safety Data

• Hazardous Substances Data: 1361216-28-5(Hazardous Substances Data)

Upstream product

• 1361216-27-4 1,1,1-trifluoro-2-(4-(4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol 
• 122243-28-1 2‐(4‐bromophenyl)‐1,1,1‐trifluoropropan‐2‐ol 
• 106-37-6 1.4-dibromobenzene 

Relevant articles and documents

SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES

The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.